Study: NCT05966350

Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnosis of sensitive neuronopathy - phase 1
Description: Search of positivity with anti-AGO antibodies test

Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnosis of sensitive neuronopathy - phase 1
Description: Search of positivity with anti-AGO antibodies test

Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnosis of sensitive neuronopathy - phase 1
Description: Search of positivity with anti-AGO antibodies test

Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnosis of sensitive neuronopathy - phase 2
Description: Title of anti-AGO antibodies

Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnosis of sensitive neuronopathy - phase 2
Description: Title of anti-AGO antibodies

Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnosis of sensitive neuronopathy - phase 2
Description: Title of anti-AGO antibodies

Intervention type: OTHER
Intervention: Comparison with Chi2 method
Description: Clinical data from positive Argonaute (AGO) patients (age, sex, type of neuropathy, clinical manifestations of neuropathy, electroneuromyography , evolution of neuropathy, presence of associated autoimmune disease, response to possible immunomodulatory treatment) will be compared with those of negative patients using a Chi2 method for qualitative data.

Intervention type: OTHER
Intervention: Comparison with Chi2 method
Description: Clinical data from positive Argonaute (AGO) patients (age, sex, type of neuropathy, clinical manifestations of neuropathy, electroneuromyography , evolution of neuropathy, presence of associated autoimmune disease, response to possible immunomodulatory treatment) will be compared with those of negative patients using a Chi2 method for qualitative data.

Intervention type: OTHER
Intervention: Comparison with Chi2 method
Description: Clinical data from positive Argonaute (AGO) patients (age, sex, type of neuropathy, clinical manifestations of neuropathy, electroneuromyography , evolution of neuropathy, presence of associated autoimmune disease, response to possible immunomodulatory treatment) will be compared with those of negative patients using a Chi2 method for qualitative data.

Intervention type: OTHER
Intervention: Comparison of data with parametric Test (T-test)
Description: Clinical data from positive Argonaute (AGO) patients (age, sex, type of neuropathy, clinical manifestations of neuropathy, electroneuromyography, evolution of neuropathy, presence of associated autoimmune disease, response to possible immunomodulatory treatment) will be compared with those of negative patients using a parametric test (T-test).

Intervention type: OTHER
Intervention: Comparison of data with parametric Test (T-test)
Description: Clinical data from positive Argonaute (AGO) patients (age, sex, type of neuropathy, clinical manifestations of neuropathy, electroneuromyography, evolution of neuropathy, presence of associated autoimmune disease, response to possible immunomodulatory treatment) will be compared with those of negative patients using a parametric test (T-test).

Intervention type: OTHER
Intervention: Comparison of data with parametric Test (T-test)
Description: Clinical data from positive Argonaute (AGO) patients (age, sex, type of neuropathy, clinical manifestations of neuropathy, electroneuromyography, evolution of neuropathy, presence of associated autoimmune disease, response to possible immunomodulatory treatment) will be compared with those of negative patients using a parametric test (T-test).

Intervention type: OTHER
Intervention: Comparison of data with non-parametric test (ANNOVA)
Description: Clinical data from positive Argonaute (AGO) patients (age, sex, type of neuropathy, clinical manifestations of neuropathy, electroneuromyography , evolution of neuropathy, presence of associated autoimmune disease, response to possible immunomodulatory treatment) will be compared with those of negative patients using a non-parametric (ANNOVA).

Intervention type: OTHER
Intervention: Comparison of data with non-parametric test (ANNOVA)
Description: Clinical data from positive Argonaute (AGO) patients (age, sex, type of neuropathy, clinical manifestations of neuropathy, electroneuromyography , evolution of neuropathy, presence of associated autoimmune disease, response to possible immunomodulatory treatment) will be compared with those of negative patients using a non-parametric (ANNOVA).

Intervention type: OTHER
Intervention: Comparison of data with non-parametric test (ANNOVA)
Description: Clinical data from positive Argonaute (AGO) patients (age, sex, type of neuropathy, clinical manifestations of neuropathy, electroneuromyography , evolution of neuropathy, presence of associated autoimmune disease, response to possible immunomodulatory treatment) will be compared with those of negative patients using a non-parametric (ANNOVA).